EPHYLA

What EPHYLA does

EPHYLA is an independent French biotech laboratory founded in 2006 and headquartered in Arzal, Brittany, that designs and develops naturally derived active ingredients for cosmetic and dermocosmetic applications. The company operates an integrated resource-to-active value chain spanning sustainable sourcing across France, Africa, the Amazon, and French Polynesia; biomimetic R&D combining botany, biochemistry, and biomimicry; in-house screening (including a proprietary endocrine-disruptor screening test); formulation support; and environmental impact assessment.

Its technology platform rests on an interdisciplinary team of ethnobotanists, biologists, physicochemists, and biochemists. Notable proprietary assets include the Ephygenetic Program (since 2020) exploring epigenetic mechanisms for skin longevity, lamellar mineral systems and Pickering emulsions that mirror the lipid architecture of the stratum corneum, neurocosmetics research into skin–nervous system interactions, and over 15 years of research on DKK1-regulated pigmentation. The company has produced two patented innovations and operates Ecoseastem, a spin-off for coral-ecosystem impact assessment.

EPHYLA generates revenue primarily through project-based B2B professional services contracts with cosmetic brands and large cosmetic groups, offering co-development from idea to pilot, sustainable sourcing, efficacy evidence, and formulation support. Pricing is quote-based and not publicly disclosed. The company employs 7 people, operates without documented external funding, and serves customers globally through direct enterprise field sales.

Name

EPHYLA

Legal name

EPHYLA

Website

https://ephyla.fr

Company type

Private

Founded year

2006

Operating status

Operating

Headcount range

1–10 employees

Short description

EPHYLA is an independent French biotech laboratory (founded 2006, 7 employees) that co-develops naturally derived cosmetic active ingredients for cosmetic brands and large groups, combining biomimetic R&D, sustainable sourcing across four ecosystems, and proprietary screening tools.

Ownership category

akta.pro rank

Headquarters

HQ city

Arzal

HQ country

France

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Biotech Active Ingredient Co-development: From idea to pilot, Ephyla designs naturally derived active ingredients and builds a scientific roadmap through to industrialization. Revenue generated through project-based development contracts with cosmetic brands.
2. Sourcing and Sustainable Value Chains: Structuring responsible local value chains with traceability, quality and field practices. Creates local value while securing resources for active ingredient development.
3. Biomimetic R&D Services: Turning observation of living systems into innovation: mechanism identification, screening, active selection and scientific concepts.
4. Efficacy Evidence and Scientific Valorization: Evaluation plans and production of claim-ready data with clear synthesis for R&D and marketing teams.
5. Formulation and Application Lab Services: Integration of actives into formulas through prototypes, dosage guidance, compatibility work and clean, effective concepts.
6. Impact Assessment and Eco-responsibility: Integration of environmental impact upstream through indicators, technical tradeoffs and sustainability criteria for better-controlled innovation.
7. Technical Support and Documentation: Technical assets for B2B deployment including traceability, quality, data sheets and integration support.
8. Available Active Ingredients: Offer available active ingredients alongside custom co-development for brands with different timelines and differentiation needs.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

EPHYLA is an independent French biotech laboratory that designs and co-develops naturally derived active ingredients for cosmetic and dermocosmetic applications. It controls the full resource-to-active value chain through sustainable local sourcing, biomimetic R&D (botany, biochemistry, green chemistry extraction), in-house proprietary screening, formulation support, and efficacy evidence generation for B2B partners.

Product overview

EPHYLA is an independent French biotech laboratory that designs and develops naturally derived active ingredients for cosmetic and dermocosmetic applications. The company operates a comprehensive service portfolio centered on biotech active ingredient co-development, encompassing sourcing and sustainable value chains, biomimetic R&D, efficacy evidence, formulation support, and environmental impact assessment. Key proprietary offerings include an endocrine-disruptor screening test, the Ecoseastem coral ecosystem impact assessment spin-off, and advanced research programs in epigenetics (Ephygenetic) and neurocosmetics. The company deploys nature-inspired innovation through technologies such as lamellar mineral systems, Pickering emulsions, and palmoplantar pigmentation modulation. EPHYLA's integrated approach spans from field observation and ethnobotany through green chemistry extraction, in-house screening, and formulation, serving cosmetic brands and laboratories in France and internationally.

Differentiator

Problem solved

Functional benefit

Products and services

• Biotech Active Ingredient Co-Development End-to-end co-development service from idea to pilot, designing naturally derived active ingredients and building a scientific roadmap through to industrialization for cosmetic and dermocosmetic brands.
• Sourcing and Sustainable Value Chains Structuring responsible local value chains with traceability, quality assurance, and field practices to secure botanical resources and create local economic value across France, Africa, Polynesia and beyond.
• Biomimetic R&D and Living-System Exploration Interdisciplinary research combining botany, biochemistry, and biomimicry to turn observation of living systems into innovation through mechanism identification, screening, active selection, and scientific concepts.
• Efficacy Evidence and Scientific Valorization Evaluation plan development and production of claim-ready performance data with clear synthesis for partner R&D, quality, and marketing teams.
• Formulation and Application Lab Integration support for actives into cosmetic formulas through prototypes, dosage guidance, compatibility work, and clean, effective concept development.
• Impact Assessment and Eco-Responsibility Environmental impact integration from earliest stages through indicators, technical tradeoffs, and sustainability criteria for better-controlled innovation, including coral-ecosystem impact assessment via Ecoseastem.
• Technical Support and Documentation Technical assets for B2B deployment including traceability documentation, quality data sheets, and integration support for partner brands and laboratories.
• Endocrine-Disruptor Screening Test Proprietary in-house screening tool offered as a standalone service to anticipate regulatory issues before they become roadblocks, evaluating formulas for endocrine-disruptor concerns affecting children and pregnant women.
• Ecoseastem Coral-Ecosystem Impact Assessment Spin-off service enabling evaluation of active ingredient compatibility with marine ecosystems and measurement of coral impact, supporting partner environmental responsibility metrics.

Quantifiable outcome

• Up to 40% lower carbon footprint through local production
• +3 more outcomes

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature8 records

Partnerships

One partnership is on record.

• EcoseastemcoreStrategic or Co-development PartnerSpin-off company specializing in coral-ecosystem impact assessment. Through this partnership, Ephyla can evaluate active ingredient compatibility with marine ecosystems, providing additional environmental responsibility metrics for developed ingredients. This capability allows partners to assess the marine environmental impact of their cosmetic formulations.

Scale indicators7 records

Recent moves7 records

Expansion highlights4 records

Broad incumbents

• Symrise (Cosmetic Ingredients): Major flavor and fragrance house with a sizeable cosmetic ingredients portfolio including biotech-derived actives. Comparable in serving global cosmetic brands with specialty ingredients, but as one division within a multi-billion-euro diversified specialty chemicals group.
• Lucas Meyer Cosmetics (IFF): IFF-owned developer of natural and biotech cosmetic actives with phospholipid and microbiome-focused platforms. Directly comparable product/market overlap, but operates as part of a multi-billion ingredient house rather than an independent R&D boutique.
• Evonik Personal Care: Specialty ingredients supplier for cosmetics including biotech and naturally derived actives. Overlaps in customer base and product category but with the resources of a global specialty chemicals company rather than an independent lab.
• Sederma (Croda): Specialty cosmetic actives subsidiary of Croda International, developing bio-inspired and naturally derived ingredients for skin care. Comparable because it sells differentiated, claim-supported cosmetic actives to the same global brand customers, but with vastly greater scale and a broader portfolio.
• Givaudan Active Beauty: Division of Givaudan focused on cosmetic actives and natural ingredient innovation, including biotech and microbiome-friendly platforms. Directly comparable product category and customer base, but operates at fragrance-company scale with global commercial reach Ephyla lacks.
• SEPPIC (Air Liquide Healthcare Beauty): French subsidiary of Air Liquide developing specialty ingredients including natural-origin cosmetic actives. Comparable as a French-headquartered cosmetic-ingredients specialist serving global brands, with parent-company resources beyond Ephyla's scale.
• BASF Care Creations: Personal-care division of BASF supplying cosmetic actives, including bio-based and sustainable ingredients. Targets the same brand customers with broader R&D and manufacturing capacity; comparable technology adjacency but vastly larger scale.

Direct peers

• Active Concepts: Independent supplier of naturally derived and biotech cosmetic ingredients to brands and formulators globally. Comparable as a boutique-to-mid-sized cosmetic active-ingredients developer with a similar specialty/B2B positioning and emphasis on natural-origin claims.
• BiotechMarine (SEPITRA group): French company specializing in marine biotechnology-based cosmetic active ingredients from seaweeds and marine organisms. Closely comparable niche (marine/extreme-environment bioactives for cosmetics) with similar B2B specialty actives model.
• Silab: Independent French biotech that designs and manufactures natural active ingredients for the cosmetic industry from its own R&D. Closest direct peer: same geography, same specialty positioning (botanical/biotech cosmetic actives), similar B2B model selling to cosmetic brands worldwide.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks7 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/ephyla

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about EPHYLA